GMIPulse：医療マーケットインテリジェンスのサブスクリプション

Global Market Insights Inc.では、最高の戦略的価値を提供するために設計された最先端のビジネスインテリジェンス (BI) 対応プラットフォーム、GMIPulseを提供しています。GMIPulseでは、包括的できめ細かい市場データ、競合情勢の分析、業界エコシステムの詳細情報を提供し、お客様の独自ニーズに合わせてカスタマイズ可能な、適応性の高いサブスクリプションサービスを提供しています。このプラットフォームは、あらゆる市場調査のニーズに対応し、最新動向と技術進歩を確実に先取りします。

GMIPulseの長所

• 1. 正確な市場データへの容易なアクセス：GMIPulseは、精度の高い本物の市場データに瞬時にアクセスして、戦略的意思決定のための正確な最新情報を提供します。
• 2. 包括的な市場調査ソリューション：包括的な市場調査ツールとして、GMIPulseは幅広い業界をカバーし、詳細な分析と予測を提供し、市場力学を効果的にナビゲートします。
• 3. 詳細な競合情勢：競合情勢や企業プロファイルに関する包括的な考察を提供し、競合他社や業界ベンチマーキングを徹底的に理解できます。
• 4. 業界エコシステムの理解：GMIPulseは、業界のエコシステムを深く理解し、技術の進歩と業界動向への影響を追跡します。
• 5. カスタム可能な顧客プロファイル：オーダーメイド式の顧客プロファイルにより、最新の成長機会を特定し、特定の市場ニーズを理解し、戦略立案を強化することができます。
• 6. 技術動向の追跡：最新の技術動向と市場への影響を把握し、将来の展開に備えます。
• 7. 最新レポートへのアクセス：加入者は、過去に発表されたレポートや今後発表予定のレポートにアクセスすることができ、常に最新の市場情報を入手することができます。
• 8. インタラクティブで使いやすいインターフェース：当プラットフォームのインタラクティブなインターフェイスは、シームレスなユーザー体験を保証します。
• 9. アナリストとの充実した面談時間：アナリストによる戦略的支援や詳細な説明へのアクセスが向上し、十分な情報に基づいた意思決定が可能になります。
• 10. 安全なログイン：パスワードで保護されたすべてのレポートへのアクセスをお楽しみ頂けます。

GMIPulseの優れた利点

• 1. レポートへの即時アクセス：GMIPulseは、お客様に包括的な市場レポートへの直接アクセスを即座に提供し、タイムリーで十分な情報に基づいた意思決定を促進します。
• 2. MyraAI, GMI Pulse内のMyraAI Assistanceの導入：データに関する洞察に、あらゆる言語で、誰もがアクセスできるようにする画期的な機能です。多言語サポートにより、MyraAIは複雑なレポートをシームレスに翻訳し、質問にリアルタイムで回答します。
• 3. インタラクティブダッシュボード：GMI Pulseの全ユーザーがインタラクティブダッシュボードを利用できるようになり、データとの関わり方が大きく変わりました。地域やセグメントなどで簡単にデータをフィルタリングできるため、最も重要なことに集中することができます。シンプルなインターフェイスにより、技術的なスキルがなくても調整を行うことができ、リアルタイムの更新により、作業中に生きた洞察を得ることができます。
• 4. オーダーメイドレポート：業界リーダーがお客様のニーズに合わせてカスタマイズした、市場動向・技術開発・イノベーションの詳細についてのレポートにアクセスできます。
• 5. プライオリティセールス・サポート：クラス最高のセールスサポートとアシスタンスを迅速に提供し、顧客サービス体験を向上させます。
• 6. マーケットトラッカー：すべての市場動向と出来事への効率的なアクセスにより、最新情報を常時入手し、戦略的計画と意思決定に立てることができます。
• 8. 価格面のメリット：包括的かつ費用対効果が高く、お客様のご予算とニーズに合ったレポートをご提供します。

業界フォーカス：医療

• 分析装置
• バイオテクノロジー
• 薬物・機器コンビネーション製品
• 医療用IT
• 医療機器
• 医療サービス
• 医薬品

GMIPulseはBI対応プラットフォームを通じて、比類のない戦略的価値を提供します。GMIPulseは、カスタム可能でインタラクティブなインターフェース、正確なデータ、包括的な市場考察を備えており、競争の激しい医療市場で一歩先を行くために不可欠なツールです。今すぐ加入すれば、市場調査と戦略立案能力の可能性を最大限に引き出すことができます。

Global Market Insights Inc. offers GMIPulse, a cutting-edge, Business Intelligence (BI)-enabled platform designed to deliver the finest strategic value. GMIPulse offers an adaptable subscription service, customizable to meet your unique needs, providing comprehensive and granular market data, competitive landscape insights, and an in-depth understanding of industry ecosystems. This platform is your go-to solution for all market research needs, ensuring you stay ahead with the latest trends and technological advancements.

Advantages of GMIPulse

• 1. Easy Access to Accurate Market Data: GMIPulse provides instant access to granular and authentic market data, empowering you with precise and up-to-date information for strategic decision-making.
• 2. Comprehensive Market Research Solution: As your all-encompassing market research tool, GMIPulse covers a wide array of industries, offering detailed analyses and forecasts to help you navigate market dynamics effectively.
• 3. In-Depth Competitive Landscape: The platform offers comprehensive insights into competitive landscapes and company profiles, enabling you to understand your competitors and industry benchmarks thoroughly.
• 4. Understanding Industry Ecosystems: GMIPulse allows you to gain a profound understanding of industry ecosystems, tracking technological advancements and their impact on industry trends.
• 5. Customized Client Profiles: Tailor-made client profiles help you identify the latest growth opportunities and understand specific market needs, enhancing your strategic planning.
• 6. Technology Tracking Stay informed about the latest technological trends and their implications on the market, ensuring you are well-prepared for future developments.
• 7. Access to Latest Reports: Subscribers receive access to previously published reports and upcoming releases, keeping you updated with the most recent market intelligence.
• 8. Interactive and User-Friendly Interface: The platform's interactive interface ensures a seamless user experience, allowing you to navigate through data effortlessly and derive meaningful insights efficiently.
• 9. Enhanced Analyst Hours: Benefit from improved access to analysts for strategic assistance and in-depth explanations, ensuring you make well-informed decisions.
• 10. Secure Login: Enjoy password-protected access to all reports, ensuring your data security and confidentiality.

Exceptional Benefits of GMIPulse

• 1. Instant Report Access GMIPulse offers clients direct access to comprehensive market reports instantly, facilitating timely and informed decision-making.
• 2. MyraAI, Introducing MyraAI Assistance within GMI Pulse: a game-changing feature that makes data insights accessible to everyone, in any language. With multilingual support, MyraAI seamlessly translates complex reports and answers your questions in real-time, breaking down language barriers for effortless, intuitive data exploration.
• 3. Interactive Dashboard We're excited to announce that the Interactive Dashboard is now available to all GMI Pulse users, changing the way you interact with your data. With easy data filtering by region, segment, and more, you can focus on what matters most. The simple interface lets you make adjustments without technical skills, and real-time updates provide live insights as you work.
• 4. Tailor-Made Reports Access customized reports detailing market trends, technological developments, and innovations by industry leaders, tailored to your specific needs.
• 5. Priority Sales Support Receive best-in-class sales support and assistance promptly, enhancing your customer service experience.
• 6. Market Tracker Stay updated with streamlined access to all market trends and happenings, aiding in strategic planning and decision-making.
• 7. Pricing Benefits Obtain reports that are not only comprehensive but also cost-effective, tailored to fit your budget and needs.

Industry Focus: Healthcare

The healthcare industry is undergoing rapid transformation driven by technological advancements, regulatory changes, and increasing demand for innovative treatments and services. GMIPulse provides in-depth insights into the following key clusters within the healthcare industry:

Analytical Instruments

The global analytical instruments market provides a critical scientific discovery tool and a QA and regulatory platform in all industries. The increase in advancement in technology, enhanced agency, and private sector R&D spending, and further utilization in pharmaceuticals, biopharmaceuticals, monitoring of health, and monitoring of the environment contributed to an observable upward trend.

The total market value for analytical instruments was reasonable valuations by 2024, with the market pricing trajectory indicating an observable compound annual growth rate (CAGR) between 2025-2034. This larger market contains several subcategories, such as chromatography, elemental analysis, immunoassay, supplies and laboratory equipment, microscopy, molecular analysis, and spectroscopy for vital analytical work in research institutions, clinical laboratories, and industrial quality control activities.. The molecular analysis segment is attractive for well-established growth opportunities from utilization patterns of increasingly high-throughput and precision methodologies in diagnostics and research.

The spectroscopy category is impressive from multiple technologies and different segments, whereas the USD 4 billion molecular spectroscopy category in 2023 is expected to exceed an estimated CAGR of 6% during 2024-2032, with specialized markets such as the USD 1.3 billion IR spectroscopy category in 2023 possibly expecting a 5% CAGR during the period 2024-2032. The sophisticated analytical methods utilize advancements in next-generation sequencing, polymerase chain reaction, and mass spectrometry to improve research capability and diagnostic accuracy.

The primary drivers of the market include increasing spending on R&D in the pharmaceutical industry, strict compliance with regulations, integration via artificial intelligence and automation, and expanding applications in clinical diagnostics and environmental testing. The industry is being enabled by miniaturization trends, greater sensitivity and accuracy of analyzers, and increasing demand for portable and point-of-care analytical solutions. Emerging manufacturing technologies, digitalization, and intelligent laboratory designs continue to transform analytical procedures and operational efficiency in all analytical instrument subcategories.

Biotechnology

The global biotechnology industry is one of the most agile and fastest-growing sectors in modern science and medicine, fueled by advancements in genetic engineering, personalized medicine, and novel therapeutics. India's biotech industry, as reported by Invest India, is fast emerging as one of the prime drivers of economic and technological progress, and it contributes approximately 4% to the world's biotech market, with exemplary capabilities in agricultural biotechnology, biopharmaceuticals, and vaccines.

This broad market covers key subcategories such as biopharmaceuticals, bioservices, and biotechnology R&D, each covering necessary segments of scientific innovation, therapeutic development, and commercial biotechnology applications in various industries like healthcare, agriculture, and industrial biotechnology. The biopharmaceutical segment shows outstanding growth prospects with the total biopharmaceutical market worldwide pegged at USD 422.5 billion in 2024, growing from USD 453.7 billion in 2025 to USD 921.5 billion in 2034 at a CAGR of 8.2%, fueled by rising demands for targeted therapies and biologics.

Support for biotechnology R&D infrastructure shows remarkable momentum. The bioreactors market was valued at USD 10.4 billion in 2023 and will grow at 11.8% CAGR from 2024 to 2032, while the contract research organization (CRO) market will reach USD 59.8 billion in 2023 and expand at 8.1% CAGR from 2024 to 2032, supported by increasing public and private R&D spending worldwide. Each of these niches illustrates the commitment of this sector to improved scientific discovery and therapeutic development.

Growth drivers include aging populations worldwide, the rising prevalence of chronic disease, government incentives for new therapies, and significant venture capital funding into biotechnology. The industry enjoys the benefits of cutting-edge manufacturing tools, trends toward personalized medicine, and pro forma collaborations between biotech firms and large pharmaceutical companies. Gene editing, cell therapies, artificial intelligence integration, and precision medicine advances continue to transform therapeutic research and commercial biotechnology products in all biotechnology submarkets.

Drug Device Combination

The global drug device combination products market is a groundbreaking union of pharmaceutical and medical device technologies, with exceptional growth fueled by rising demand for minimally invasive techniques, improved patient outcomes, and technological advancements that merge drug delivery with medical devices. The international drug device combination products market is expected to have robust growth during the next several years. It is a dynamic market that involves key subcategories like drug coated devices, drug filled devices, and therapeutic systems, each serving unique therapeutic applications in the cardiovascular, oncology, and other specialty medical procedures.

Support therapeutic systems have immense growth prospects, with the smart drug delivery systems market valued at USD 10.5 billion in 2023, which is poised to rise from USD 12 billion in 2024 to USD 48.3 billion by 2034 at a CAGR of 17%, led by increased uptake of digital health technologies. The transdermal drug delivery system market reached USD 29 billion in sales in 2022 and is expected to observe 8% CAGR from 2023 to 2032 due to a spectacular increase in cases of chronic diseases.

The major market drivers are the growing incidence of chronic disease, regulatory favor for innovative combination products, technological convergence by nanotechnology and smart materials, and growing preference for patient-focused treatment options. The industry is aided by improved therapeutic effectiveness, better patient compliance, and fewer side effects in comparison to conventional drug delivery systems. Innovative production processes, trends in personalized medicine, and collaborative business strategies between pharmaceutical firms and medical device makers continue to fuel innovation in all subcategories of drug device combinations.

Healthcare IT

The global healthcare IT market is a disruptive force in modern healthcare delivery, and it will continue to achieve unconstrained growth due to digital transformation, a requirement for interoperability, and increasing demand for data-driven healthcare solutions. The aggregate effect of AI, traditional machine learning, and deep learning can entail a total cost savings of up to $360 billion in healthcare expenditures. This wide-ranging market includes key subsegments such as artificial intelligence, health services, healthcare outsourcing, payer/provider solutions, surveillance solutions, and telehealth, which each focus on key digital transformation needs across healthcare organizations and patient care delivery systems.

The segment of artificial intelligence showcases high growth prospects in healthcare IT, with the healthcare generative AI valued at USD 1.8 billion in 2023, rising to USD 20.2 billion by the year 2032. Applications of AI cover diagnostic aid, medical imaging, and patient engagement, with the market for AI in patient engagement solutions worth USD 5 billion in 2023 and expanding at 20.1% CAGR from 2024 through 2032. These technologies use machine learning, natural language processing, and predictive analysis to improve clinical decision-making, operational effectiveness, and patient outcomes in various healthcare environments.

Major drivers of the market include regulatory compliance needs, adoption of value-based care, cybersecurity threats, and the increasing focus on patient-centric models of care delivery.

Fast digitalization was highlighted as the challenge expected to impact the global healthcare systems for the better in 2025, reflecting the healthcare sector's continuing transition from outdated systems to new technologies. The sector is currently optimistic with the adoption of cloud computing, interoperability standards, and mobile health solutions that facilitate care coordination, reduce costs, and improve access across all health IT sectors.

Medical Devices

The medical devices market is one of the most innovative and dynamic healthcare sectors, with intense growth fueled by technology development, aging populations, and rising incidence of chronic conditions necessitating advanced medical interventions. The global medical device market is expected to witness steady growth, with worldwide yearly sales set to grow more than 5% annually, reaching nearly USD 800 billion by the year 2030. This has accelerated the demand for advanced devices and data-driven health care services, the prevalence of lifestyle-related diseases, and opportunities in growth markets, mainly in China and India. The cardiovascular devices market has huge upside potential. The global market for cardiovascular devices is expected to reach USD 7.5 billion in 2024 and is projected to grow at a CAGR of 13.5% from 2025-2034 as demand for minimally invasive surgeries continues to grow.

The wearable medical devices market demonstrates outstanding growth, with the market value at USD 120.1 billion in 2024 and is anticipated to rise to USD 543.9 billion by 2034, with a CAGR of 16.5% over the forecast period. The highly developed healthcare devices make use of technology for real-time monitoring, diagnostics, and treatment purposes in various specialties in medicine. Major market drivers are aging population transitions in demographics, rising incidence of chronic diseases, technology assimilation in the form of IoT and AI functions, and growing healthcare infrastructure in developing economies. The industry is supported by regulatory convergence, adoption of digital health, personalized medicine shifts, and value-based healthcare models driven by enhanced patient outcomes. Materials science innovation, miniaturization technologies, and connectivity solutions continue to transform device capabilities and patient accessibility in all medical device subcategories.

Medical Services

The global medical services sector is a fundamental pillar to the healthcare infrastructure and is currently going through unprecedented growth driven by ageing populations, advancing technological capabilities, and increased demand for comprehensive patient care within the frameworks of a vast array of service delivery models. Healthcare profit pools are increase at 4% CAGR from $654 billion in 2021 to $790 billion by 2026. This growth will be substantially driven by an increased shift toward Medicare as the over-65 population is projected to rise by 3% annually over the forecast period. This large market covers key subcategories, such as diagnostic services, inpatient and outpatient services, laboratory services, long-term care services, and surgical services, each capturing key healthcare delivery needs across a range of patient populations and care settings.

The diagnostic services segment exhibits good growth momentum, and it is reported that specialty areas are experiencing incredible growth. The market for ophthalmology diagnostics had an estimated size of USD 8.7 billion in 2022 and is anticipated to see a CAGR of 4.4% between 2023 and 2032 attributed to the increasing prevalence of eye diseases. Laboratory services continue to be the backbone diagnostic of healthcare system, pathology laboratory equipment market size was USD 33 billion in 2022 and is projected to be USD 75 billion by 2032 due to the increasing incidence of chronic disease. Complementing diagnostic features, the diagnostics segment of the medical display market accounted for USD 2.2 billion revenue in 2022 due to the central position played by it in healthcare wherein proper diagnosis is imperative for patient treatment.

Major drivers in the market are demographic trends to aging populations, rising chronic disease burden, technology integration in the form of digital health solutions, and growing healthcare access in emerging markets. The industry is aided by telemedicine implementation, AI-based diagnostic solutions, and value-based care platforms focusing on patient outcomes. Regulatory compliance, quality standards and health workforce development remains critical to optimize service delivery in all medical service sub-designate.

Pharmaceuticals

The global pharmaceuticals business is one of the most crucial and fastest-growing healthcare industries, fueled by aging populations, rising rates of chronic diseases, and ongoing innovation in drug formulation and manufacturing technology. India's pharmaceutical industry was worth USD 50 billion in FY 2023-24, with USD 23.5 billion representing domestic consumption and USD 26.5 billion in exports, as per government statistics. This large market is comprised of several distinct categories and market segments, including active pharmaceutical ingredients, clinical nutrition, medicines for specific diseases, drug delivery systems, finished drugs, pharmaceutical excipients, manufacturing processes, and vaccines; all of which are critical healthcare and regulatory needs in global markets.

The active pharmaceutical ingredients segment is the backbone of pharmaceutical production, where the market was worth more than USD 228.5 billion in 2022 and is projected to grow at over 6.5% CAGR during the period from 2023 to 2032 due to expanding demand for drugs and treatment of rare diseases. Targeted segments of APIs exhibit impressive growth, such as high potency active pharmaceutical ingredients market worth USD 27.1 billion in 2024 and projected to advance at a 8.8% CAGR during 2025-2034 and small molecule API market worth USD 194.7 billion in 2024 and projected to advance at a 5.8% CAGR during 2025-2034, with escalating incidence of chronic diseases.

Major drivers for the market are increasing healthcare spending, regulatory convergence globally, patent losses giving rise to generic opportunities, and technological innovation in precision medicine, biologics, and personalized therapeutics. The overall sector benefits from substantial research and development investment, continued growth in contract manufacturing, and expanded market access in growing emerging economies. The digitization of the sector and the incorporation of AI-assisted drug discovery and next generation manufacturing technologies are fundamentally changing the efficacy and efficiency of the development, manufacturing, and regulatory compliance of ALL categories and market segments in pharmaceutical development and manufacturing.

GMIPulse by Global Market Insights Inc. offers unparalleled strategic value through its BI-enabled platform. With its customizable and interactive interface, accurate data, and comprehensive market insights, GMIPulse is your essential tool for staying ahead in the competitive healthcare market landscape. Subscribe today to unlock the full potential of your market research and strategic planning capabilities.